Facebook Linkedin Twitter
Inside Precision Medicine In Another Win for CRISPR, FDA Approves Casgevy for Beta Thalassemia

CRISPR Therapeutics

An illustration of a CRISPR-Cas9 gene editing protein cutting a DNA helix
News & Features

In Another Win for CRISPR, FDA Approves Casgevy for Beta Thalassemia

Malorye Branca -
0
Scientist pipetting sample into a vial for DNA testing
News & Features

Newcomer Tome Acquires Replace TX in $250M Gene Editing Deal

Malorye Branca -
0
Sickle Cell disease - 3D Illustration of sickled blood cells on a dark background
News & Features

Two Gene Therapies for Sickle Cell Disease Get FDA Nod, Including First Ever CRISPR-Based Therapy 

Malorye Branca -
0
Angled DNA Double Helix
News & Features

One and Done? How CRISPR Is Changing the Clinical Outlook for Multiple Diseases

Kathy Vuksanaj -
0
Using the Epigenome to Guide Development of Gene Edited Therapies
News & Features

Using the Epigenome to Guide Development of Gene Edited Therapies

Helen Albert -
0
Blood clot made of red blood cells, platelets and fibrin protein strands. Thrombus
News & Features

Bluebird Tightens Sickle Cell Race with BLA for Gene Therapy

Malorye Branca -
0

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine